HB miRDx™ is one of three miRNA detection technologies (RT-qPCR based) in the world. This technique possesses multiplexing capabilities and allows for accurate sequencing of PCR products, in addition to boasting high sensitivity and specificity.
Sequencing is uniquely available with HB miRDx™ Technology.
Accurate miRNA diagnostic biomarker validation to develop highly accurate detection kits.
Analysis using multiple biomarkers enables accurate diagnosis.
Highly competitive in terms of cost and convenience.
HB miR Multi Assay Kit™ has higher reactivity due to precise hybridization during cDNA synthesis for accurate detection & analysis.
HB miR Multi Assay Kit™ is miRNA detection and analyzing method to quantify the miRNA by using Real-time PCR and demonstrates high sensitivity and accuracy.
HB miRDx™ EarlyHCC Kit is RT-qPCR based early liver cancer (hepatocellular carcinoma, HCC) screening kit that detects circulating miRNA biomarkers via liquid biopsy of blood.
RT-qPCR based Analysis Kit
HB miR Multi Assay Kit™ is miRNA detection and analyzing method to quantify the miRNA by using Real-time PCR and demonstrates high sensitivity and accuracy.
Pangyo Silicon Park A-201 35, Pangyo-ro 255beon-gil, Bundang-gu,
Seongnam-si, Gyeonggi-do, Korea, 13486
Business registration number : 135-86-48279
Tel : 1522-7026
Fax : 031-548-2135
E-mail : info@heimbiotek.com